Malignancies in β-thalassemia patients: a single-center experience and a concise review of the literature
✍ Scribed by L. BENETATOS; V. ALYMARA; A. VASSOU; K. L. BOURANTAS
- Book ID
- 110108578
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 70 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1751-5521
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Liver transplantation may occasionally be indicated in patients with unique clinical scenarios. Little is known regarding the outcomes of patients who have had a pancreatic resection prior to, in combination with, or after liver transplantation. A retrospective review of all patients undergoing live
## Abstract ## BACKGROUND. Bortezomib is active in heavily pretreated multiple myeloma patients; the dose‐limiting toxicity is peripheral neuropathy (PN). ## METHODS. The authors retrospectively reviewed the incidence, severity, and risk factors for PN in 78 patients who received bortezomib. The